modelR03BA08

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Ciclesonide
ATC code:R03BA08
route:inhalation
compartments:2
dosage:800mg
volume of distribution:2.9L
clearance:2.0L/h/kg
other parameters in model implementation

Ciclesonide is an inhaled corticosteroid used in the prophylactic treatment of asthma and allergic rhinitis. It is a prodrug that is activated in the lungs to its active metabolite, des-ciclesonide. Ciclesonide is approved and commonly used today for asthma maintenance therapy.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult subjects after inhalation administration of ciclesonide.

References

  1. Rohatagi, S, et al., & Barrett, JS (2003). Population pharmacokinetics and pharmacodynamics of ciclesonide. Journal of clinical pharmacology 43(4) 365–378. DOI:10.1177/0091270002250998 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12723457

  2. Xu, J, et al., & Derendorf, H (2010). Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. Journal of clinical pharmacology 50(10) 1118–1127. DOI:10.1177/0091270009354994 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20150524

  3. Teramoto, T, et al., & Nishima, S (2012). Repeated-dose pharmacokinetics of inhaled ciclesonide (CIC-HFA) in Japanese children with bronchial asthma: a phase I study. Allergology international : official journal of the Japanese Society of Allergology 61(4) 619–624. DOI:10.2332/allergolint.11-OA-0378 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23000724

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)